Subba Chintalacharuvu
Executive Director - Translational Immunology Genentech
• Proven leader with successful track record of driving programs from target discovery to IND submission, contributing to 16 IND documents in various clinical trial phases
• Expertise in various therapeutic areas – RA, IBD, NASH, Pulmonary (IPF & COPD), CKD and Immuno-oncology
• Extensive experience managing global matrix teams, collaborating with KOLs and academic scientists and fostering effective partnerships to achieve program milestones.
Seminars
Thursday 23rd October 2025
Roundtable Discussion: Scaling Spatial & Single-Cell Workflows to Unlock Consistent, High-Quality Multi-Omics Data to Discover Novel Targets
2:30 pm
- How to expand from small pilots to routine use of spatial and single-cell pipelines across disease programs?
- What are the practical steps to standardise sampling, assays, and data integration for reproducibility across sites and teams?
- How to build fit-for-purpose infrastructure and partnerships that reduce variability and deliver reliable insights for drug discovery?
Thursday 23rd October 2025
Panel Discussion: Leveraging Spatial Biology to Unlock Novel Insights into Complex Disease for Enhanced Therapeutic & Biomarker Development
11:30 am
- What are some of the most promising ways spatial biology is helping us better understand complex disease mechanisms that traditional approaches may miss?
- How can we translate novel spatial insights into robust, clinically relevant biomarkers and therapeutic targets that hold up across different patient populations?
- What practical steps are needed to integrate spatial biology more effectively into discovery and development pipelines?
